P4508Procedural success and clinical outcome of the resheathable Portico transcatheter aortic valve using primarily left subclavian access

Transcatheter Aortic Valve Replacement: A Review Article

Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...

Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience.

OBJECTIVES The purpose of this study was to demonstrate the feasibility and procedural outcomes with a new self-expanding and repositionable transcatheter heart valve. BACKGROUND Transcatheter aortic valve replacement is a viable option for selected patients with severe symptomatic aortic stenosis. However, suboptimal prosthesis positioning may contribute to paravalvular regurgitation, atriov...

The Lotus transcatheter aortic valve: a next-generation repositionable, resheathable and recapturable prosthesis

Symptomatic severe aortic stenosis occurs in 2–4% of people aged over 65 years, with calcific degeneration being the predominant etiology in the developed world. Surgical valve replacement has been and remains the gold-standard treatment modality, yet a significant number of high-risk individuals are denied or refuse this potentially life-saving treatment. Transcatheter aortic valve replacement...

Trans-subclavian approach for transcatheter aortic valve replacement.

Supraclavicular Subclavian access for Sapien Transcatheter aortic valve replacement- a novel approach

BACKGROUND Within the trans-subclavian approach, procedural techniques can vary widely, and reported access generally refers to an infraclavicular axillary approach. We describe and report the use of a novel supraclavicular true subclavian approach for transcatheter aortic valve replacement (TAVR) exclusively for implantation of Sapien 3 valves. CASE PRESENTATION We report our first five cons...